Synthesis of rheumatoid factor in vitro: implications for the pathogenesis of rheumatoid arthritis.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D001402:B-Lymphocytes / Q000378:metabolism; D006052:Gold Sodium Thiomalate / Q000627:therapeutic use; D006462:Hemolytic Plaque Technique; D004854:Herpesvirus 4, Human; D006801:Humans; D007074:Immunoglobulin G / Q000494:pharmacology; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D010396:Penicillamine / Q000627:therapeutic use; D011043:Pokeweed Mitogens / Q000494:pharmacology; D012016:Reference Values; D012217:Rheumatoid Factor / Q000096:biosynthesis*; D014018:Tissue Distribution; D014412:Tumor Virus Infections / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D007074:Immunoglobulin G; D007130:Immunoglobulin Idiotypes; D011043:Pokeweed Mitogens; D006052:Gold Sodium Thiomalate; D012217:Rheumatoid Factor; D010396:Penicillamine